Kaempferol’s promise in fighting triple-negative breast cancer

FHS
July 24, 2024
10:23 pm

Review highlights kaempferol’s potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.

WHO publishes report introducing updated terminology for airborne pathogens

Following consultation with public health agencies and experts, the World Health Organization (WHO) publishes a global technical consultation report introducing updated terminology for pathogens that

April 22, 2024

Volta Medical presents results from first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with conventional treatment for persistent atrial fibrillation patients – Biotech Investments

EQS-News: Volta Medical SAS / Key word(s): Study results Volta Medical presents results from first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with conventional

May 21, 2024

Omicron subvariant BA.5 can cause more severe disease

Omicron-derived virus variants are currently responsible for most SARS-CoV-2 infections worldwide. Compared to earlier virus variants, Omicron rarely causes severe disease.

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.